Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

Details for Australian Patent Application No. 2010301042 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Rosenberg, Steven A.; Chinnasamy, Dhanalakshmi

Agent Fisher Adams Kelly

Pub. Number AU-A-2010301042

PCT Pub. Number WO2011/041093

Priority 61/247,625 01.10.09 US

Filing date 14 September 2010

Wipo publication date 7 April 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/041093 Priority application(s): WO2011/041093

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010301043-Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions

2010301029-Method for using recording rules and previous value selection rules for presence information in a communications system